Page last updated: 2024-12-11

ecdysterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ecdysterone: A steroid hormone that regulates the processes of MOLTING or ecdysis in insects. Ecdysterone is the 20-hydroxylated ECDYSONE. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

20-hydroxyecdysone : An ecdysteroid that is ecdysone substituted by a hydroxy group at position 20. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5459840
CHEMBL ID224128
CHEBI ID16587
SCHEMBL ID22086
MeSH IDM0006958
PubMed CID12304165
CHEMBL ID3348837
MeSH IDM0006958

Synonyms (93)

Synonym
MLS002207226
cholest-7-en-6-one, 2,3,14,20,22,25-hexahydroxy-, (2beta,3beta,5beta,22r)-
nsc-629484
beta-ecdysterone
(22r)-2beta,3beta,14alpha,20,22,25-hexahydroxy-5beta-cholest-7-en-6-one
CHEBI:16587 ,
20-oh ecdysone
brn 1917578
ai3-44727
5-beta-cholest-7-en-6-one, 2-beta,3-beta,14,20,22,25-hexahydroxy-, (22r)-
cholest-7-en-6-one, 2,3,14,20,22,25-hexahydroxy-, (2-beta,3-beta,5-beta,22r)-
2-beta,3-beta,14,20,22,25-hexahydroxy-5-beta-cholet-7-en-6-one
nsc 629484
beta-ecdysone
crustecdyson
(2s,3r,5r,9r,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-[(1r,2r)-1,2,5-trihydroxy-1,5-dimethyl-hexyl]-2,3,4,5,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-6-one
the-7
commisterone
viticosterone
isoinokosterone
2,3,14-trihydroxy-10,13-dimethyl-17-(1,2,5-trihydroxy-1,5-dimethyl-hexyl)-1,2,3,4,5,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-6-one
ecdysteron
(2beta,3beta,5beta)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one
ecdysterone
crustecdysone
5289-74-7
20-hydroxyecdysone
20-hydroxyecdysone, >=93% (hplc), powder
20E ,
(2beta,3beta,5beta,22r)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one
20-e
MLS001164644
smr000539832
bio101
20-hydroxyecdyson
bio 101
bio-101
CHEMBL224128 ,
20-hydroxy-.alpha.-ecdysone
ecdysten
ekdisten
(2s,3r,5r,9r,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-6-one
LMST01010209
2beta,3beta,14alpha,20,22r,25-hexahydroxy-5beta-cholest-7-en-6-one
AKOS004120029
bdbm50326777
A829299
HMS2230L09
ecdystene
beta-ecdisone
unii-779a7kpl0y
779a7kpl0y ,
(+)-ecdysterone
S2417
20-hydroxyecdysone [mi]
cholest-7-en-6-one, 2,3,14,20,22,25-hexahydroxy-, (2.beta.,3.beta.,5.beta.,22r)-
20-hydroxyecdysone [who-dd]
bio 101 [who-dd]
NKDFYOWSKOHCCO-YPVLXUMRSA-N
SCHEMBL22086
Q-201054
AC-19603
AC-34796
cholest-7-en-6-one, 2,3,14,20,22,25-hexahydroxy-, (2b,3b,5b,22r)-
HB3718
DTXSID5040388
b-ecdysone
b-ecdysone,commisterone
(2s,3r,5r,9r,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-((2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl)-1,2,3,4,5,9,10,11,12,13,14,15,16,17-tetradecahydro-6h-cyclopenta[a]phenanthren-6-one
20-hydroxy-a-ecdysone
.beta-ecdysterone
(2alpha,3alpha,5alpha,22r)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one
'2-beta,3-beta,14,20,22,25-hexahydroxy-5-beta-cholet-7-en-6- one'
Q423338
HY-N6979
edysterone
CCG-269554
CS-0007134
2beta,3beta,14alpha,20r,22r,25-hexahydroxy-5beta-cholest-7-en-6-one
(2b,3b,5b,22r)-2,3,14,20,22,25-hexahydroxycholest-7-en-6-one
sarconeos
gtpl11987
?- ecdysone
NCGC00346709-01
CHEMBL3348837
(2s,3r,5r,9r,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-((2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl)-2,3,4,5,9,11,12,13,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-6(10h)-one
2,3,4,5,9,11,12,13,14,15,16,17-dodecahydro-
ecdysterone,(s)
1h-cyclopenta[a]phenanthren-6(10h)-one
2,3,14-trihydroxy-10,13-dimethyl-17-
(2s,3r,5r,9r,10r,13r,14s,17s)-
((2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl)-
(2s,3r,5r,9s,10r,13r,14s,17s)-2,3,14-trihydroxy-10,13-dimethyl-17-[(2r,3r)-2,3,6-trihydroxy-6-methylheptan-2-yl]-2,3,4,5,9,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-6-one

Research Excerpts

Overview

Edysterone is a naturally occurring steroid hormone. It presents in arthropods and in a number of plants as an insect defence tool.

ExcerptReferenceRelevance
"Ecdysterone is a naturally occurring steroid hormone, which presents in arthropods and in a number of plants as an insect defence tool. "( Ecdysterone prevents negative effect of acute immobilization stress on energy metabolism of rat liver mitochondria.
Baev, AY; Charishnikova, OS; Khasanov, FA; Khushbaktova, ZA; Levitskaya, YV; Makhmudov, AR; Nebesnaya, KS; Rakhmedova, MT; Syrov, VN, 2022
)
3.61
"Ecdysterone is an insect steroid hormone."( The effect of ecdysterone on cerebral vasospasm following experimental subarachnoid hemorrhage in vitro and in vivo.
Chen, Z; Feng, H; Liu, Z; Tang, WH; Xi, G; Zhang, JH, 2008
)
1.43

Effects

Edysterone has been crosslinked in situ to polytene chromosomes of salivary glands of Drosophila melanogaster by photoactivation.

ExcerptReferenceRelevance
"β-ecdysterone has been demonstrated to protect PC12 cells against neurotoxicity."( β‑ecdysterone protects against apoptosis by promoting autophagy in nucleus pulposus cells and ameliorates disc degeneration.
He, CJ; Wen, F; Yang, AF; Yu, J; Zhang, ZW, 2019
)
1.79
"Ecdysterone has been found in a great many plants and animals and has some valuable pharmaceutical properties. "( Supercritical fluid extraction of ecdysterone from the roots of Achyranthes bidentata BL.
Chen, M; Chen, T; Liu, B; Zheng, Y, 2008
)
2.07
"Ecdysterone has been crosslinked in situ to polytene chromosomes of salivary glands of Drosophila melanogaster by photoactivation. "( Localization of ecdysterone on polytene chromosomes of Drosophila melanogaster.
Gronemeyer, H; Pongs, O, 1980
)
2.05

Actions

Eccdysterone and D3 may cause antiradical effects through the same mechanisms. The activity of the studied enzyme forms in the fat body of Anterahea pernyi pupae is blocked by actinomycin D, an inhibitor of transcriptional processes.

ExcerptReferenceRelevance
"Ecdysterone produced an increase of AChE in rat brain slices."( Ecdysterone induces acetylcholinesterase in mammalian brain.
Aragones, MD; Catalan, RE; Godoy, JE; Martinez, AM, 1984
)
2.43
"Ecdysterone and D3 may cause antiradical effects through the same mechanisms."( Effects of vitamin D3 and ecdysterone on free-radical lipid peroxidation.
Korniets, GV; Kuzmenko, AI; Morozova, RP; Nikolenko, IA, 1997
)
1.32
"Ecdysterone-induced increase of activity of the studied enzyme forms in the fat body of Anterahea pernyi pupae is blocked by actinomycin D, an inhibitor of transcriptional processes, and by puromycin, a translation inhibitor."( [Ecdysterone induces the activity of multiple forms of acid phosphatase and malate dehydrogenase in fat bodies of Anterahea pernyi pupae].
Filippovich, IuB; Kholodova, IuD; Kindruk, NL; Korniets, GV; Kutuzova, NM; Miladera, K; Moroz, NS,
)
1.76
"Ecdysterone produced an increase in 14C-acetate incorporation into triglycerides."( Alterations in rat lipid metabolism following ecdysterone treatment.
Aragones, MD; Catalán, RE; Godoy, JE; Martinez, AM; Miguel, BG; Robles, A, 1985
)
1.25

Treatment

Edysterone treatment normalized the levels of stable NO metabolites, ability to generate superoxide, iNOS and nNOS activity, but not bilirubine level, NR and AII activity. Treatment also prevented glutamate-induced rat hippocampal cell loss.

ExcerptReferenceRelevance
"Ecdysterone treatment also prevented glutamate-induced rat hippocampal cell loss."( Ecdysterones from Rhaponticum carthamoides (Willd.) Iljin reduce hippocampal excitotoxic cell loss and upregulate mTOR signaling in rats.
Chen, S; Chu, T; Gao, L; Huang, J; Lin, R; Shang, L; Wang, G; Wang, J; Wei, N; Wu, J; Zhang, Y, 2017
)
2.62
"Ecdysterone co-treatment was apparently similar to the suppression of proliferation."( The effect of ecdysterone on cerebral vasospasm following experimental subarachnoid hemorrhage in vitro and in vivo.
Chen, Z; Feng, H; Liu, Z; Tang, WH; Xi, G; Zhang, JH, 2008
)
1.43
"Ecdysterone treatment normalized the levels of stable NO metabolites, ability to generate superoxide, iNOS and nNOS activity, but not bilirubine level, NR and AII activity."( [The role of nitric oxide and superoxide synthesis in protective mechanism of ecdysterone in the heart mitochondria of rats with streptozotocin-induced diabetes].
Korkach, IuP; Kotsiuruba, AV; Prysiazhna, OD; Rudyk, OV; Sahach, VF, 2007
)
1.29
"Treatment with ecdysterone resulted in significantly increased cell proliferation as compared to the control cells (P<0.05), but no significant differences were found in cells treated with 100, 150, and 200 µg/ml ecdysterone (P>0.05)."( [Effect of ecdysterone on the proliferation of human umbilical cord mesenchymal stem cells in vitro].
Feng, CJ; Fu, XB; Huang, S; Ma, K; Wu, X; Zhang, YZ; Zhang, ZL, 2011
)
1.1

Toxicity

ExcerptReferenceRelevance
" Methoxyfenozide was the most toxic followed by tebufenozide, halofenozide, and RH-5849."( Significance of absorption, oxidation, and binding to toxicity of four ecdysone agonists in multi-resistant cotton leafworm.
Carton, B; Decombel, L; Smagghe, G; Tirry, L, 2001
)
0.31
" While two of the bisacylhydrazines (coded as RH-5992 and RH-2485) are predominantly toxic to lepidopteran pests, RH-5849, which has not been commercialized, has a broader spectrum of toxicity."( Comparative toxicity and ecdysone receptor affinity of non-steroidal ecdysone agonists and 20-hydroxyecdysone in Chironomus tentans.
Dhadialla, TS; Lezzi, M; Smagghe, G, 2002
)
0.31
"Amyloid-β (Aβ) plays a pivotal role in Alzheimer's disease (AD) pathogenesis and in toxic mechanisms such as oxidative stress, mitochondrial dysfunction, calcium turbulence, and apoptosis induction."( Diverse ecdysterones show different effects on amyloid-β42 aggregation but all uniformly inhibit amyloid-β42-induced cytotoxicity.
Du, XY; Feng, Y; Ling, TJ; Liu, RT; Sun, XS; Wang, L; Xue, D; Yang, SG; Yang, Y; Zhang, X; Zhao, M, 2010
)
0.79
"BIO101 showed a good safety profile with only mild to moderate adverse events and a satisfactory pharmacokinetic profile."( A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults.
Balducci, C; Daudigny, L; Del Signore, S; Dilda, PJ; Dioh, W; Dupont, P; Lafont, R; Tourette, C; Veillet, S, 2023
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
" Pharmacodynamic effects were investigated with regard to myostatin, procollagen-III-amino-terminal propeptide (PIIINP), myoglobin, creatine-kinase Muscle Brain (CKMB), renin and aldosterone plasma/serum levels."( A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults.
Balducci, C; Daudigny, L; Del Signore, S; Dilda, PJ; Dioh, W; Dupont, P; Lafont, R; Tourette, C; Veillet, S, 2023
)
0.91
"BIO101 showed a good safety profile with only mild to moderate adverse events and a satisfactory pharmacokinetic profile."( A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults.
Balducci, C; Daudigny, L; Del Signore, S; Dilda, PJ; Dioh, W; Dupont, P; Lafont, R; Tourette, C; Veillet, S, 2023
)
0.91
"BIO101 shows a good safety and pharmacokinetic profile that led to the selection of doses for the subsequent interventional clinical trials of Phase 2 in age-related sarcopenia (SARA-INT) and Phase 3 in Covid-19 (COVA)."( A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults.
Balducci, C; Daudigny, L; Del Signore, S; Dilda, PJ; Dioh, W; Dupont, P; Lafont, R; Tourette, C; Veillet, S, 2023
)
0.91

Compound-Compound Interactions

ExcerptReferenceRelevance
"Workers of three termite species, Coptotermes formosanus Shiraki (Blattodea: Rhinotermitidae), Coptotermes gestroi (Wasmann) (Blattodea: Rhinotermitidae), and Reticulitermes flavipes (Kollar) (Blattodea: Rhinotermitidae), were force-fed with cellulose media pads treated with 20-hydroxyecdysone (20E) alone and in combination with noviflumuron for 3 d to examine their mortality time trends up to 14 d (including 3-d exposure time)."( Mortality Time Trends of Three Subterranean Termite Species When Exposed to 20-Hydroxyecdysone, Alone and in Combination With Noviflumuron.
Carnohan, L; Su, NY, 2018
)
0.48

Bioavailability

ExcerptReferenceRelevance
" Analog 901 was previously demonstrated to both enhance biostablility and bioavailability properties in adult heliothines and thus may be a potential candidate for topical application as a diapause-terminating agent."( Conformational aspects and hyperpotent agonists of diapause hormone for termination of pupal diapause in the corn earworm.
Denlinger, DL; Nachman, RJ; Zhang, Q; Zubrzak, P, 2009
)
0.35
" Bioavailability of 20HE, whether consumed alone or with leucine, also remained low at all doses ingested."( Evaluating the effect of 20-hydroxyecdysone (20HE) on mechanistic target of rapamycin complex 1 (mTORC1) signaling in the skeletal muscle and liver of rats.
Anthony, TG; Bargoud, AR; DeOliveira, CM; Graf, BL; Kuhn, PE; Mirek, ET; Phillipson-Weiner, L; Raskin, I; Wetstein, B, 2015
)
0.42
" The pharmacokinetics, bioavailability and metabolism of Post have been assessed in male rats after ingestion and injection."( The complex metabolism of poststerone in male rats.
Balducci, C; Bertho, G; Caradeuc, C; Carbonne, C; Dinan, L; Durand, JD; Foucault, AS; Girault, JP; Guibout, L; Lafont, R, 2021
)
0.62
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

Significantly higher increases in muscle mass were observed in those participants that were dosed with ecdysterone. Transcription in vitro of promoters containing such elements is stimulated up to 100-fold by added purified ecdystersone receptor.

ExcerptRelevanceReference
" Transcription in vitro of promoters containing such elements is stimulated up to 100-fold by added purified ecdysterone receptor, depending on receptor dosage and the number of elements present."( Ecdysterone receptor is a sequence-specific transcription factor involved in the developmental regulation of heat shock genes.
Amin, J; Luo, Y; Voellmy, R, 1991
)
1.94
" The experiments on dosage dependency revealed two EIPs whose rate of synthesis correlates with the dosage of the 2B3-5 X-chromosomal region."( Trans-regulation of ecdysterone-induced protein synthesis in Drosophila melanogaster salivary glands.
Dubrovsky, EB; Zhimulev, IF, 1988
)
0.6
" By consideration of the dose-response characteristics, it is estimated that MIH may be active in the subpicomolar range."( Neurohormonal control of ecdysteroid biosynthesis by Carcinus maenas Y-organs in vitro, and preliminary characterization of the putative molt-inhibiting hormone (MIH).
Webster, SG, 1986
)
0.27
" Dose-response analyses revealed that 20-hydroxyecdysone indeed had a stimulatory effect on JH synthesis by the CA, but only when the glands were complexed with the brain-corpora cardiaca."( Brain-mediated 20-hydroxyecdysone regulation of juvenile hormone synthesis by the corpora allata of the tobacco hornworm, Manduca sexta.
Bollenbacher, WE; Bowen, MF; Gilbert, LI; Granger, NA; Whisenton, LR, 1985
)
0.27
" The effectiveness of a given dosage of steroid is dependent on the developmental stage, with older animals being more affected."( Hormonal control of rates of metamorphic development in the tobacco hornworm Manduca sexta.
Schwartz, LM; Truman, JW, 1983
)
0.27
" Using a graded series of dilutions of PTTH extract it was shown that a dose-response relationship could be obtained for Sarcophaga similar to that demonstrated or the Manduca sexta PTTH-prothoracic gland system."( In vitro activity of dipteran ring glands and activation by the prothoracicotropic hormone.
Bollenbacher, WE; Gilbert, LI; Roberts, B, 1984
)
0.27
" The dose-response curves are in agreement with those obtained for other hormonal effects in both the Kc line and the intact animal."( An ecdysteroid-induced alteration in the cell cycle of cultured Drosophila cells.
Alvarez, CM; Bohman, R; O'Connor, JD; Stevens, B, 1980
)
0.26
" The dose-response curves of myotropic and non-myotropic factors indicate that (i) proctolin, L-glutamate, octopamine, leucokinin-VI, leucopyrokinin, ecdysone and 20-hydroxy-ecdysone, or equivalent structures, might be involved in Galleria mellonella oviposition control, and (ii) that only the novel wax moth neuropeptide has the ability to trigger egg laying in that insect."( Separation of oviposition-stimulating peptides and myotropic factors from head extracts of Galleria mellonella L.: comparative effects of myotropic and non-myotropic factors on egg laying.
Abdoun, K; Baudry-Partiaoglou, N; Cohen, P; Mesnier-Sabin, M; Nicolas, P, 1995
)
0.29
" The host cells accumulate correct transcripts of the Bombyx gene in a gene dosage dependent way."( Expression of a Bombyx cytoplasmic actin gene in cultured Drosophila cells: influence of 20-hydroxyecdysone and interference with expression of endogenous cytoplasmic actin genes.
Abraham, EG; Bosquet, G; Mounier, N, 1993
)
0.29
" Results of dose-response experiments revealed that EGF had a maximum fibroblast stimulation at 66078 +/- 1979 counts per minute (cpm), with peak counts on day 6 of culture, as measured by [3H]-thymidine incorporation."( Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy.
Prete, PE, 1997
)
0.3
" These RNAs were induced in day 2 fifth larval epidermis in vitro by 20-hydroxyecdysone (20E) in the absence of JH with dose-response and time courses similar to the induction of pupal commitment."( Juvenile hormone prevents ecdysteroid-induced expression of broad complex RNAs in the epidermis of the tobacco hornworm, Manduca sexta.
Hiruma, K; Riddiford, LM; Shinoda, T; Zhou, B, 1998
)
0.3
" Our study sought a suitable dosage form with continuous release of the drug lasting several weeks for implantation into agricultural animals."( 20-Hydroxyecdysone release from biodegradable devices: the effect of size and shape.
Dittrich, M; Hunt, AJ; Opletal, L; Smart, JD; Solich, P, 2000
)
0.31
" EDS was shown to exert influence on the apoptosis-inducing effect of Ars, which decreased the apoptotic cell number at the dosage of 50 and 200 mg/L, but a contrary effect occurred while at the dosage of 800 mg/L."( [Protective effect of ecdysterone against sodium arsenite-induced endothelial cell apoptosis].
Wang, WJ; Wu, X, 2003
)
0.63
"To assess whether nerve growth factor (NGF) expression would respond to booster dosing with the inducing agent ponasterone A, human embryonic kidney cells (HEK-293) were transfected with human NGF cDNA."( Nerve growth factor expression response to induction agent booster dosing in transfected human embryonic kidney cells.
Bradshaw, RA; Calvert, JW; Dhar, S; Evans, GR; McConnell, MP; Naran, S; Nguyen, T; Sundine, MJ, 2005
)
0.33
" Dose-response experiments revealed that RH-5992 was even more potent than 20E."( Comparative effects of a non-steroidal ecdysone agonist RH-5992 and 20-hydroxyecdysone in a lepidopteran cell line (IAL-PID2).
Auzoux-Bordenave, S; Bozzolan, F; Debernard, S; Mottier, V; Porcheron, P; Queguiner, I; Siaussat, D; Solvar, M, 2005
)
0.33
" Evidence is provided that this dose-response difference is related to whether or not an effective dose of tebufenozide is ingested by the first instar prior to the peak of moulting hormone (20-hydroxyecdysone) in first instars."( Diapause disruption with tebufenozide for early-instar control of the spruce budworm, Choristoneura fumiferana.
Arif, B; Bauce, E; Cusson, M; Doucet, D; Frisco, C; Palli, SR; Retnakaran, A; Tomkins, B, 2007
)
0.34
" The simultaneous measurement of the expression of green fluorescent protein by the reporter gene and of the fluorescent label allows construction of the dose-response profile of the hormone at the single-cell level."( Quantitative cell-based reporter gene assays using droplet-based microfluidics.
Baret, JC; Beck, Y; Billas-Massobrio, I; Griffiths, AD; Moras, D, 2010
)
0.36
" In addition, the bioaccumulation of CLD was measured in the muscle tissue of Macrobrachium rosenbergii to underline potential dose-response relationship."( Effects of chlordecone on 20-hydroxyecdysone concentration and chitobiase activity in a decapod crustacean, Macrobrachium rosenbergii.
Boulangé-Lecomte, C; Caupos, F; Dodet, N; Forget-Leray, J; Geraudie, P; Gismondi, E; Lafontaine, A; Lagadic, L; Lemoine, S; Thomé, JP, 2016
)
0.43
" Significantly higher increases in muscle mass were observed in those participants that were dosed with ecdysterone."( Ecdysteroids as non-conventional anabolic agent: performance enhancement by ecdysterone supplementation in humans.
Ambrosio, G; Botrè, F; de la Torre, X; Diel, P; Goebel, C; Isenmann, E; Joseph, JF; Kazlauskas, R; Mazzarino, M; Parr, MK; Zimmer, P, 2019
)
0.96
" The primary objective was to evaluate safety and pharmacokinetics (PK), including dosing of circulating metabolites."( A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults.
Balducci, C; Daudigny, L; Del Signore, S; Dilda, PJ; Dioh, W; Dupont, P; Lafont, R; Tourette, C; Veillet, S, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
animal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in animals that include diverse creatures from sponges, insects to mammals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (8)

ClassDescription
20-hydroxy steroidAny hydroxy steroid that in which the steroid skeleton contains a hydroxy substituent at position 20.
ecdysteroidA class of steroids that include insect moulting and sex hormones.
14alpha-hydroxy steroid
3beta-sterolA sterol in which the hydroxy group at position 3 has beta- configuration.
2beta-hydroxy steroid
22-hydroxy steroid
25-hydroxy steroid
phytoecdysteroid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
Molting Hormone Biosynthesis821

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
eyes absent homolog 2 isoform aHomo sapiens (human)Potency375.52691.199814.641950.1187AID488837; AID504895
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency28.18380.050127.073689.1251AID588590
gemininHomo sapiens (human)Potency1.41250.004611.374133.4983AID624297
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
UltraspiracleNezara viridula (southern green stink bug)IC50 (µMol)2.84900.13001.33674.5000AID1111829; AID1111843; AID1111844
UltraspiracleNezara viridula (southern green stink bug)Ki2.75000.10001.01673.0000AID1111843; AID1111844
20-hydroxy-ecdysone receptor Nezara viridula (southern green stink bug)IC50 (µMol)2.84900.13001.33674.5000AID1111829; AID1111843; AID1111844
20-hydroxy-ecdysone receptor Nezara viridula (southern green stink bug)Ki2.75000.10001.01673.0000AID1111843; AID1111844
Ecdysone receptorLucilia cuprina (Australian sheep blowfly)IC50 (µMol)5.50000.90003.20005.5000AID513908
Protein ultraspiracleDrosophila melanogaster (fruit fly)IC50 (µMol)0.04570.04570.04570.0457AID1111835
Ecdysone receptorDrosophila melanogaster (fruit fly)IC50 (µMol)0.04570.00130.54502.5704AID1111835; AID431525
Ultraspiracle Leptinotarsa decemlineata (Colorado potato beetle)IC50 (µMol)0.43650.43650.43650.4365AID1111834
20-hydroxy-ecdysone receptor Leptinotarsa decemlineata (Colorado potato beetle)IC50 (µMol)0.43650.43650.43650.4365AID1111834
Ultraspiracle protein Spodoptera frugiperda (fall armyworm)IC50 (µMol)0.16600.16600.16600.1660AID1111826
20-hydroxy-ecdysone receptor Spodoptera frugiperda (fall armyworm)IC50 (µMol)0.16600.16600.16600.1660AID1111826
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (90)

Assay IDTitleYearJournalArticle
AID1256305Drug metabolism assessed as (2S,3R,10R,13R,17S)-2,3,6-trihydroxy-10,13-dimethyl-17-((2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl)-3,4,10,11,12,13,16,17-octahydro-1H-cyclopenta[a]phenanthren-7(2H)-one formation at 120 mg at pH 6 to 6.5 measured at 6 to 7 h2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID1256295Drug metabolism assessed as (2S,3R,5R,9S,10S,13R,14S,17S)-2,3,9,14-tetrahydroxy-10,13-dimethyl-17-((2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl)-2,3,4,5,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6(10H)-one formation at 120 mg incubate2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID513909Binding affinity to Bovicola ovis recombinant ecdysone receptor ligand binding domain after 3 hrs by fluorescence polarization assay2010Bioorganic & medicinal chemistry, Aug-01, Volume: 18, Issue:15
Synthesis, binding and bioactivity of gamma-methylene gamma-lactam ecdysone receptor ligands: advantages of QSAR models for flexible receptors.
AID683086Inhibition of human ABCB1 expressed in mouse L5178 cells assessed as 95% inhibition of cell proliferation at compound-doxorubicin ratio of 20.4:1 after 48 hrs by MTT assay2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Significant activity of ecdysteroids on the resistance to doxorubicin in mammalian cancer cells expressing the human ABCB1 transporter.
AID1194493Antioxidant activity assessed as ABTS radical scavenging activity incubated for 6 mins2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID1256294Half life of the compound by HPLC analysis in presence of NaOH2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID332665Antifungal activity against Candida albicans1995Journal of natural products, Feb, Volume: 58, Issue:2
4-Dehydroecdysterone, a new ecdysteroid from the zoanthid Parazoanthus sp.
AID1256307Drug metabolism assessed as (2S,3R,5R,10S,13R,17S)-2,3,7-trihydroxy-10,13-dimethyl-17-((2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl)-2,3,4,5,12,13,16,17-octahydro-1H-cyclopenta[a]phenanthren-6(10H)-one formation at 120 mg incubated for 2 days measured at 2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID1194498Antimicrobial activity against Staphylococcus aureus ATCC 25923 incubated for 24 hrs by microtiter plate dilution method2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID1111826Binding affinity to Spodoptera frugiperda (fall armyworm) EcR2011Pest management science, Nov, Volume: 67, Issue:11
Isoforms of the heteropteran Nezara viridula ecdysone receptor: protein characterisation, RH5992 insecticide binding and homology modelling.
AID1293713Cytotoxicity against human HuH7 cells assessed as reduction in cell viability after 72 hrs by MTS assay2016Bioorganic & medicinal chemistry letters, May-01, Volume: 26, Issue:9
Ecdysones from Zoanthus spp. with inhibitory activity against dengue virus 2.
AID1256303Drug metabolism assessed as (2S,3R,10R,13R,14S,17S)-2,3,6,14-tetrahydroxy-10,13-dimethyl-17-((2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl)-3,4,10,11,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-7(2H)-one formation at 120 mg incubated for 2 days2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID1194499Antimicrobial activity against Enterococcus faecalis ATCC 29212 incubated for 24 hrs by microtiter plate dilution method2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1256309Induction of Akt phosphorylation in mouse C2C12 cells at 30 ug/ml pretreated with compound for 24 hrs followed by fresh medium with compound addition measured after 2 hrs by Western blot analysis2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID1256297Drug metabolism assessed as (2S,3R,5S,9S,10S,13R,14S,17S)-2,3,9,14-tetrahydroxy-10,13-dimethyl-17-((2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl)-2,3,4,5,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6(10H)-one formation at 120 mg incubate2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID1194494Antioxidant activity assessed as ferric-reducing antioxidant power after 20 mins at 50 degC by UV spectrophotometry2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID1256299Drug metabolism assessed as 9beta,20-dihydroxyecdysone formation at 120 mg incubated for 2 days measured at 0.5 to 48 hrs by HPLC-DAD analysis in presence of NaOH2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID1194500Inhibition of BchE in human plasma at 1 mg/ml incubated for 30 mins using butyrylthiocholine substrate at 37 degC by DTNB dye based spectrophotometry2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID286453Toxicity against larvae of orally dosed Acyrthosiphon pisum Harris2007Journal of natural products, May, Volume: 70, Issue:5
Ecdysteroids from Serratula wolffii roots.
AID431525Binding affinity to ecdysone receptor ligand binding domain in Drosophila melanogaster assessed as number of hydrogen bonds formed2009Bioorganic & medicinal chemistry, Aug-15, Volume: 17, Issue:16
Evaluation of hydrogen bonds of ecdysteroids in the ligand-receptor interactions using a protein modeling system.
AID1256301Drug metabolism assessed as (2S,3R,5R,10S,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-((2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl)-2,3,4,5,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-6(10H)-one formation at 120 mg incubated for 2 days m2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID677866Cytotoxicity against human CCRF-CEM cells at 100 uM by XTT assay2012Journal of natural products, Jun-22, Volume: 75, Issue:6
Polyhydroxylated steroidal glycosides from Paris polyphylla.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1194497Antimicrobial activity against Escherichia coli ATCC 25922 incubated for 24 hrs by microtiter plate dilution method2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID513908Binding affinity to Lucilia cuprina recombinant ecdysone receptor ligand binding domain after 3 hrs by fluorescence polarization assay2010Bioorganic & medicinal chemistry, Aug-01, Volume: 18, Issue:15
Synthesis, binding and bioactivity of gamma-methylene gamma-lactam ecdysone receptor ligands: advantages of QSAR models for flexible receptors.
AID683083Inhibition of human ABCB1 expressed in mouse L5178 cells assessed as 75% inhibition of cell proliferation at compound-doxorubicin ratio of 20.4:1 after 48 hrs by MTT assay2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Significant activity of ecdysteroids on the resistance to doxorubicin in mammalian cancer cells expressing the human ABCB1 transporter.
AID1256308Effect on glucose consumption in mouse C2C12 cells at 30 ug/ml after 24 hrs2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID1256298Drug metabolism assessed as (2S,3R,5S,9R,10R,13R,14S,17S)-2,3,14-trihydroxy-10,13-dimethyl-17-((2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl)-2,3,4,5,9,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6(10H)-one formation at 120 mg incubated fo2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID1293714Selectivity index, ratio of CC50 for human HuH7 cells to EC50 for Dengue virus 2 DN454009A infected in human HuH7 cells2016Bioorganic & medicinal chemistry letters, May-01, Volume: 26, Issue:9
Ecdysones from Zoanthus spp. with inhibitory activity against dengue virus 2.
AID1194492Antioxidant activity assessed as DPPH radical scavenging activity incubated for 30 mins by UV absorption spectrometry2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID683080Inhibition of human ABCB1 expressed in mouse L5178 cells assessed as 50% inhibition of cell proliferation at compound-doxorubicin ratio of 20.4:1 after 48 hrs by MTT assay2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Significant activity of ecdysteroids on the resistance to doxorubicin in mammalian cancer cells expressing the human ABCB1 transporter.
AID1194495Antioxidant activity assessed as catalase activity by measuring hydrogen peroxide disappearance per mg protein measured for 1 min at 25 degC2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID1111829Binding affinity to Nezara viridula EcR2011Pest management science, Nov, Volume: 67, Issue:11
Isoforms of the heteropteran Nezara viridula ecdysone receptor: protein characterisation, RH5992 insecticide binding and homology modelling.
AID1111843Displacement of [3H]PonA from recombinant Nezara viridula EcR102011Pest management science, Nov, Volume: 67, Issue:11
Isoforms of the heteropteran Nezara viridula ecdysone receptor: protein characterisation, RH5992 insecticide binding and homology modelling.
AID1194496Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 incubated for 24 hrs by microtiter plate dilution method2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID683076Inhibition of human ABCB1 pump expressed in mouse L5178 cells assessed as fluorescence activity ratio at 20 uM for 10 mins by flow cytometry relative to control2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Significant activity of ecdysteroids on the resistance to doxorubicin in mammalian cancer cells expressing the human ABCB1 transporter.
AID1256300Drug metabolism assessed as polypodine B formation at 120 mg incubated for 2 days measured at 0.5 to 48 hrs by HPLC-DAD analysis in presence of NaOH2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID1111844Displacement of [3H]PonA from recombinant Nezara viridula EcR112011Pest management science, Nov, Volume: 67, Issue:11
Isoforms of the heteropteran Nezara viridula ecdysone receptor: protein characterisation, RH5992 insecticide binding and homology modelling.
AID1111835Binding affinity to Drosophila melanogaster EcR2011Pest management science, Nov, Volume: 67, Issue:11
Isoforms of the heteropteran Nezara viridula ecdysone receptor: protein characterisation, RH5992 insecticide binding and homology modelling.
AID1256302Drug metabolism assessed as (2S,3R,10R,11R,13R,17S)-2,3,6,11-tetrahydroxy-10,13-dimethyl-17-((2R,3R)-2,3,6-trihydroxy-6-methylheptan-2-yl)-3,4,10,11,12,13,16,17-octahydro-1H-cyclopenta[a]phenanthren-7(2H)-one formation at 120 mg incubated for 2 days measu2015Journal of natural products, Oct-23, Volume: 78, Issue:10
Oxidized Metabolites of 20-Hydroxyecdysone and Their Activity on Skeletal Muscle Cells: Preparation of a Pair of Desmotropes with Opposite Bioactivities.
AID1293709Antiviral activity against Dengue virus 2 DN454009A infected in human HuH7 cells assessed as inhibition of viral RNA level measured 72 hrs post infection by qRT-PCR method2016Bioorganic & medicinal chemistry letters, May-01, Volume: 26, Issue:9
Ecdysones from Zoanthus spp. with inhibitory activity against dengue virus 2.
AID1111834Binding affinity to Leptinotarsa decemlineata EcR2011Pest management science, Nov, Volume: 67, Issue:11
Isoforms of the heteropteran Nezara viridula ecdysone receptor: protein characterisation, RH5992 insecticide binding and homology modelling.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1194501Inhibition of BchE in human plasma incubated for 30 mins using butyrylthiocholine substrate at 37 degC by DTNB dye based spectrophotometry2015Bioorganic & medicinal chemistry letters, Apr-15, Volume: 25, Issue:8
New septanoside and 20-hydroxyecdysone septanoside derivative from Atriplex portulacoides roots with preliminary biological activities.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1347100qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347092qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347094qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347089qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347101qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347098qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347093qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347097qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347102qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347096qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347091qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347103qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347099qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347105qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347090qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347095qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID1347107qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347104qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1347108qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347106qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells2018Oncotarget, Jan-12, Volume: 9, Issue:4
Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (1,725)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990353 (20.46)18.7374
1990's285 (16.52)18.2507
2000's461 (26.72)29.6817
2010's461 (26.72)24.3611
2020's165 (9.57)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 45.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index45.74 (24.57)
Research Supply Index7.52 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index148.15 (26.88)
Search Engine Supply Index3.88 (0.95)

This Compound (45.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials10 (0.55%)5.53%
Trials0 (0.00%)5.53%
Reviews44 (2.40%)6.00%
Reviews0 (0.00%)6.00%
Case Studies1 (0.05%)4.05%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other1,775 (96.99%)84.16%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]